Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Cellular Biomedicine (CBMG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2014	12-2013	12-2012	12-2011	12-2010
Cash Flows From Operating Activities
Net Income	-15,475	-13,797	-7,032	-766	-175
Depreciation Amortization	4,490	5,100	102	N/A	N/A
Income taxes - deferred	N/A	-77	N/A	N/A	N/A
Accounts receivable	21	10	46	N/A	23
Accounts payable and accrued liabilities	166	41	-2,311	-109	178
Other Working Capital	-1,347	-785	-1,976	314	637
Other Operating Activity	2,424	1,052	3,712	910	-754
Operating Cash Flow	$-9,721	$-8,455	$-7,459	$348	$-90

Cash Flows From Investing Activities
PPE Investments	-312	-147	-644	N/A	N/A
Net Acquisitions	-1,486	N/A	N/A	N/A	N/A
Purchase Sale Intangibles	-9	-6	-1,082	N/A	N/A
Other Investing Activity	-9	-6	-1,082	0	0
Investing Cash Flow	$-1,806	$-153	$-1,727	$N/A	$N/A

Cash Flows From Financing Activities
Debt Repayment	N/A	N/A	N/A	-19	-45
Common Stock Issued	19,141	11,561	8,916	N/A	N/A
Other Financing Activity	-32	35	0	224	23
Financing Cash Flow	$19,110	$11,597	$8,916	$205	$-23

Exchange Rate Effect	13	42	N/A	N/A	N/A
Beginning Cash Position	7,175	4,145	4,414	50	163
End Cash Position	14,771	7,175	4,145	603	50
Net Cash Flow	$7,595	$3,030	$-269	$553	$-113

Free Cash Flow
Operating Cash Flow	-9,721	-8,455	-7,459	348	-90
Capital Expenditure	-312	-147	-644	N/A	N/A
Free Cash Flow	-10,033	-8,603	-8,103	348	-90